Division of Hematology and Oncology
- Nigel Key, MD, ChB, CRCP, received a $180,000 grant for the聽鈥淓valuating the Mechanism of Emicizumab-related Thrombotic Microangiopathy.鈥�
- Tracy L. Rose,聽MD MPH, received an聽NCI K08 grant for the project聽鈥淪elective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelial cancer.鈥�
Division of Infectious Diseases
- Ross Boyce, MD, MSc, received a 2019 Emerging Challenges in Biomedical Research Award, with PI Corbin Jones, PhD, and Dan Schrider, PhD. Learn聽more.
Division of Nephrology and Hypertension
- Jenny Flythe, MD, MPH, received an award for $116,625 from the NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), to conduct a pilot feasibility study of loop diuretics among individuals receiving hemodialysis. Learn聽more.
- Flythe聽also received an R01 award for 鈥淨T prolonging medications and sudden cardiac death among individuals on Hemodialysis.鈥�
Division of Pulmonary and Critical Care Medicine
- Blaire Wendlandt, MD, MSc, received a聽聽from the Society of Critical Care Medicine.聽Learn more.
Division of Rheumatology, Allergy and Immunology
- Saira Sheikh, MD, and聽Nigel Key, MD, ChB, CRCP, with local biotech company EpiCypher, have received a National Institute of Allergy and Infectious Diseases grant to develop and commercialize a novel blood-based assay that can be used to study and diagnose a range of diseases, from rheumatoid arthritis and lupus to cancer-associated venous thromboembolism.The total award to EpiCypher庐 is $3m over three years, with just under a $1m sub-award to 黑料网. More聽.